Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products

Clinical Cancer Research

Volumn 16, Issue 17, 2010, Pages 4446-4451

  Kang, Soonmo Peter ^a   Ratain, Mark J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALISKIREN; CINACALCET; DARUNAVIR; DEFERASIROX; ELTROMBOPAG; ERLOTINIB; ETRAVIRINE; GEFITINIB; LAPATINIB; NILOTINIB; NITAZOXANIDE; OXYBATE SODIUM; POSACONAZOLE; RASAGILINE; RIFAXIMIN; RUFINAMIDE; SORAFENIB; TAPENTADOL; TEGASEROD; VORICONAZOLE; VORINOSTAT; ZIPRASIDONE;

AREA UNDER THE CURVE; ARTICLE; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG LABELING; DRUG PACKAGING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FOOD DRUG INTERACTION; HUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; DRUG LABELING; FASTING; FOOD; FOOD-DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77956236146     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0663     Document Type: Article

References (28)

1. Parsad SD, Ratain MJ. Prescribing oral chemotherapy. BMJ 2007;334:76.
2. DeMario MD, Ratain MJ. Oral chemotherapy: rationale and future directions. J Clin Oncol 1998;16:2557-67.
3. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002;94:652-61.
4. Singh BN, Malhotra BK. Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinet 2004;43:1127-56.
5. Ratain MJ, Cohen EE. The value meal: how to save $1,700 per month or more on lapatinib. J Clin Oncol 2007;25:3397-8.
6. GlaxoSmithKline: TYKERB label http://usgskcom/products/assets/us- tykerbpdf2007.
7. Williams DD, Peng B, Bailey CK, et al. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies. Clin Ther 2009;31:764-76.
8. Scholler-Gyure M, Boffito M, Pozniak AL, et al. Effects of different meal compositions and fasted state on the oral bioavailability of etravirine. Pharmacotherapy 2008;28:1215-22.
9. Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther 1998;20:634-47.
10. Koch KM, Reddy NJ, Cohen RB, et al. Effects of food on the relative bioavailability of lapatinib in cancer patients. J Clin Oncol 2009;27:1191-6.
11. Courtney R, Pai S, Laughlin M, Lim J, Batra V. Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults. Antimicrob Agents Chemother 2003;47:2788-95.
12. Sekar V, Kestens D, Spinosa-Guzman S, et al. The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers. J Clin Pharmacol 2007;47:479-84.
13. Padhi D, Salfi M, Harris RZ. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals. Am J Ther 2007;14:235-40.
14. Ling J, Fettner S, Lum BL, Riek M, Rakhit A. Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals. Anticancer Drugs 2008;19:209-16.
15. Purkins L, Wood N, Kleinermans D, Greenhalgh K, Nichols D. Effect of food on the pharmacokinetics of multiple-dose oral voriconazole. Br J Clin Pharmacol 2003;56 Suppl 1:17-23. (Pubitemid 37491729)
16. Rubin EH, Agrawal NG, Friedman EJ, et al. A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer. Clin Cancer Res 2006;12:7039-45.
17. Galanello R, Piga A, Cappellini MD, et al. Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen. J Clin Pharmacol 2008;48:428-35.
18. Cardot JM, Lecaillon JB, Czendlik C, Godbillon J. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers. Biopharm Drug Dispos 1998;19:259-62.
19. Zhou H, Khalilieh S, Lau H, et al. Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919). J Clin Pharmacol 1999;39:911-9.
20. Services USDoHaH. Guidance for industry: food-effect bioavailability and fed bioequivalence studies. Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2002.
21. Hellriegel ET, Bjornsson TD, Hauck WW. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clin Pharmacol Ther 1996;60:601-7.
22. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009;59:56-66.
23. Ruddy KJ, Partridge AH. Adherence with adjuvant hormonal therapy for breast cancer. Ann Oncol 2009;20:401-2.
24. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr 2001;28:124-31.
25. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001;33:865-72.
26. Walsh JC, Horne R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care 2001;13:709-20.
27. Reigner B, Verweij J, Dirix L, et al. Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res 1998;4:941-8.
28. Novartis. Tasigna® (nilotinib) capsules package insert. http://www.accessdata.fda.gov/drugsatfda-docs/label/2007/022068lbl.pdf.